Correlation Between Spero Therapeutics and Pieris Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Spero Therapeutics and Pieris Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Spero Therapeutics and Pieris Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Spero Therapeutics and Pieris Pharmaceuticals, you can compare the effects of market volatilities on Spero Therapeutics and Pieris Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Spero Therapeutics with a short position of Pieris Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Spero Therapeutics and Pieris Pharmaceuticals.
Diversification Opportunities for Spero Therapeutics and Pieris Pharmaceuticals
0.56 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Spero and Pieris is 0.56. Overlapping area represents the amount of risk that can be diversified away by holding Spero Therapeutics and Pieris Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pieris Pharmaceuticals and Spero Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Spero Therapeutics are associated (or correlated) with Pieris Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pieris Pharmaceuticals has no effect on the direction of Spero Therapeutics i.e., Spero Therapeutics and Pieris Pharmaceuticals go up and down completely randomly.
Pair Corralation between Spero Therapeutics and Pieris Pharmaceuticals
Given the investment horizon of 90 days Spero Therapeutics is expected to under-perform the Pieris Pharmaceuticals. In addition to that, Spero Therapeutics is 1.55 times more volatile than Pieris Pharmaceuticals. It trades about -0.15 of its total potential returns per unit of risk. Pieris Pharmaceuticals is currently generating about -0.01 per unit of volatility. If you would invest 1,700 in Pieris Pharmaceuticals on August 28, 2024 and sell it today you would lose (16.00) from holding Pieris Pharmaceuticals or give up 0.94% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Spero Therapeutics vs. Pieris Pharmaceuticals
Performance |
| Timeline |
| Spero Therapeutics |
| Pieris Pharmaceuticals |
Spero Therapeutics and Pieris Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Spero Therapeutics and Pieris Pharmaceuticals
The main advantage of trading using opposite Spero Therapeutics and Pieris Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Spero Therapeutics position performs unexpectedly, Pieris Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pieris Pharmaceuticals will offset losses from the drop in Pieris Pharmaceuticals' long position.| Spero Therapeutics vs. Eliem Therapeutics | Spero Therapeutics vs. HCW Biologics | Spero Therapeutics vs. Scpharmaceuticals | Spero Therapeutics vs. Milestone Pharmaceuticals |
| Pieris Pharmaceuticals vs. Adaptimmune Therapeutics Plc | Pieris Pharmaceuticals vs. Mereo BioPharma Group | Pieris Pharmaceuticals vs. PDS Biotechnology Corp | Pieris Pharmaceuticals vs. Leap Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |